{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T10:40:58Z","timestamp":1780051258135,"version":"3.53.1"},"reference-count":43,"publisher":"Oxford University Press (OUP)","issue":"9","funder":[{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","award":["2012\u20132015"],"award-info":[{"award-number":["2012\u20132015"]}],"id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","award":["2014\u20132017"],"award-info":[{"award-number":["2014\u20132017"]}],"id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004326","name":"Bayer","doi-asserted-by":"publisher","award":["2013\u20132018"],"award-info":[{"award-number":["2013\u20132018"]}],"id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001003","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","award":["2013\u20132016"],"award-info":[{"award-number":["2013\u20132016"]}],"id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008497","name":"Boston Scientific","doi-asserted-by":"publisher","award":["2010\u20132012"],"award-info":[{"award-number":["2010\u20132012"]}],"id":[{"id":"10.13039\/100008497","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","award":["2010\u2013201"],"award-info":[{"award-number":["2010\u2013201"]}],"id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,9,1]]},"DOI":"10.1093\/europace\/euw169","type":"journal-article","created":{"date-parts":[[2017,2,15]],"date-time":"2017-02-15T04:48:23Z","timestamp":1487134103000},"page":"1439-1448","source":"Crossref","is-referenced-by-count":57,"title":["Adverse outcomes in patients with atrial fibrillation and peripheral arterial disease: a report from the EURObservational research programme pilot survey on atrial fibrillation"],"prefix":"10.1093","volume":"19","author":[{"given":"Marco","family":"Proietti","sequence":"first","affiliation":[{"name":"University of Birmingham Institute of Cardiovascular Sciences, City Hospital, Dudley Road, Birmingham B18 7QH, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Raparelli","sequence":"additional","affiliation":[{"name":"Department of Experimental Medicine, Sapienza-University of Rome, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Laroche","sequence":"additional","affiliation":[{"name":"EURObservational Research Programme Department, European Society of Cardiology, Sophia Antipolis, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georghe-Andrei","family":"Dan","sequence":"additional","affiliation":[{"name":"University of Medicine, \u2018Carol Davila\u2019, Colentina University Hospital, Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianna","family":"Janion","sequence":"additional","affiliation":[{"name":"\u015awi\u0119tokrzyskie Cardiology Centre, Faculty of Health Sciences, The Jan Kochanowski University, Kielce, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raluca","family":"Popescu","sequence":"additional","affiliation":[{"name":"University of Medicine, \u2018Carol Davila\u2019, Colentina University Hospital, Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianfranco","family":"Sinagra","sequence":"additional","affiliation":[{"name":"Cardiovascular Department, University Hospital Cattinara, AOU Ospedali Riuniti, Trieste, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Vijgen","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Jessa Hospitals, Hasselt, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Boriani","sequence":"additional","affiliation":[{"name":"Institute of Cardiology, Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, S.Orsola-Malpighi University Hospital, Bologna, Italy"},{"name":"Cardiology Department, University of Modena and Reggio Emilia, Policlinico di Modena, Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldo P.","family":"Maggioni","sequence":"additional","affiliation":[{"name":"EURObservational Research Programme Department, European Society of Cardiology, Sophia Antipolis, France"},{"name":"ANMCO Research Center, Firenze, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Tavazzi","sequence":"additional","affiliation":[{"name":"Maria Cecilia Hospital, GVM Care and Research, Ettore Sansavini Health Science Foundation, Cotignola, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory Y.H.","family":"Lip","sequence":"additional","affiliation":[{"name":"University of Birmingham Institute of Cardiovascular Sciences, City Hospital, Dudley Road, Birmingham B18 7QH, UK"},{"name":"Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the EORP-AF Gen Pilot Investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2016,12,9]]},"reference":[{"key":"key\n\t\t\t\t20180328150728_euw169C1","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1161\/CIR.0000000000000152","article-title":"Heart disease and stroke statistics \u2013 2015 update: a report from the American Heart Association","volume":"131","author":"Mozaffarian","year":"2014","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180328150728_euw169C2","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1161\/CIRCRESAHA.116.303849","article-title":"Epidemiology of peripheral artery disease","volume":"116","author":"Criqui","year":"2015","journal-title":"Circ Res"},{"key":"key\n\t\t\t\t20180328150728_euw169C3","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(13)61249-0","article-title":"Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis","volume":"382","author":"Fowkes","year":"2013","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180328150728_euw169C4","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1024\/0301-1526\/a000369","article-title":"Asymptomatic peripheral artery disease and antiplatelet management","volume":"43","author":"Raparelli","year":"2014","journal-title":"Vasa"},{"key":"key\n\t\t\t\t20180328150728_euw169C5","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.1161\/CIR.0b013e318276fbcb","article-title":"Measurement and interpretation of the Ankle-Brachial Index: a scientific statement from the American Heart Association","volume":"126","author":"Aboyans","year":"2012","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180328150728_euw169C6","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.ahj.2008.06.029","article-title":"Prevalence, clinical profile, and cardiovascular outcomes of atrial fibrillation patients with atherothrombosis","volume":"156","author":"Goto","year":"2008","journal-title":"Am Heart J"},{"key":"key\n\t\t\t\t20180328150728_euw169C7","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1016\/j.amjcard.2009.07.022","article-title":"Increasing prevalence of atrial fibrillation and flutter in the United States","volume":"104","author":"Naccarelli","year":"2009","journal-title":"Am J Cardiol"},{"key":"key\n\t\t\t\t20180328150728_euw169C8"},{"key":"key\n\t\t\t\t20180328150728_euw169C9","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1111\/jth.12177","article-title":"The impact of atherosclerotic vascular disease in predicting a stroke, thromboembolism and mortality in atrial fibrillation patients: a systematic review","volume":"11","author":"Anandasundaram","year":"2013","journal-title":"J Thromb Haemost"},{"key":"key\n\t\t\t\t20180328150728_euw169C10","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation","volume":"137","author":"Lip","year":"2010","journal-title":"Chest"},{"key":"key\n\t\t\t\t20180328150728_euw169C11","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1001\/jamainternmed.2013.11912","article-title":"Atrial fibrillation and the risk of myocardial infarction","volume":"174","author":"Soliman","year":"2014","journal-title":"JAMA Intern Med"},{"key":"key\n\t\t\t\t20180328150728_euw169C12","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1161\/CIRCULATIONAHA.114.014145","article-title":"Atrial fibrillation and risk of ST-segment-elevation versus non-ST-segment-elevation myocardial infarction: the Atherosclerosis Risk in Communities (ARIC) Study","volume":"131","author":"Soliman","year":"2015","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180328150728_euw169C13","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1160\/TH15-07-0612","article-title":"Ankle-Brachial Index and cardiovascular events in atrial fibrillation. The ARAPACIS Study","volume":"115","author":"Violi","year":"2016","journal-title":"Thromb Haemost"},{"key":"key\n\t\t\t\t20180328150728_euw169C14","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1161\/CIRCULATIONAHA.115.016595","article-title":"Does myocardial infarction beget atrial fibrillation and atrial fibrillation beget myocardial infarction?","volume":"131","author":"Vermond","year":"2015","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180328150728_euw169C15","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s11739-011-0637-0","article-title":"Peripheral artery disease and atrial fibrillation: a potentially dangerous combination","volume":"7","author":"Violi","year":"2012","journal-title":"Intern Emerg Med"},{"key":"key\n\t\t\t\t20180328150728_euw169C16","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1016\/j.jacc.2013.07.035","article-title":"Prevalence of peripheral artery disease by abnormal ankle-brachial index in atrial fibrillation: implications for risk and therapy","volume":"62","author":"Violi","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20180328150728_euw169C17","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1093\/eurheartj\/eht492","article-title":"Efficacy and safety of rivaroxaban compared with warfarin in patients with peripheral artery disease and non-valvular atrial fibrillation: insights from ROCKET AF","volume":"35","author":"Jones","year":"2014","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180328150728_euw169C18","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/europace\/eut373","article-title":"A prospective survey in European Society of Cardiology member countries of atrial fibrillation management: baseline results of EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot General Registry","volume":"16","author":"Lip","year":"2014","journal-title":"Europace"},{"key":"key\n\t\t\t\t20180328150728_euw169C19","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1093\/eurheartj\/ehu374","article-title":"Prognosis and treatment of atrial fibrillation patients by European cardiologists: one year follow-up of the EURObservational Research Programme-Atrial Fibrillation General Registry Pilot Phase (EORP-AF Pilot registry)","volume":"35","author":"Lip","year":"2014","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180328150728_euw169C20","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.jacc.2015.01.044","article-title":"Oral anticoagulation, aspirin, or no therapy in patients with nonvalvular AF with 0 or 1 stroke risk factor based on the CHA2DS2-VASc score","volume":"65","author":"Lip","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20180328150728_euw169C21"},{"key":"key\n\t\t\t\t20180328150728_euw169C22","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jacc.2010.09.024","article-title":"Comparative validation of a novel risk score for predicting bleeding risk in anticoagulated patients with atrial fibrillation: the HAS-BLED (Hypertension, Abnormal Renal\/Liver Function, Stroke, Bleeding History or Predisposition, Labile INR, Elderly, Drug","volume":"57","author":"Lip","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20180328150728_euw169C23","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1111\/j.1538-7836.2011.04308.x","article-title":"Impact of vascular disease in predicting stroke and death in patients with atrial fibrillation: the Danish diet, cancer and health cohort study","volume":"9","author":"Rasmussen","year":"2011","journal-title":"J Thromb Haemost"},{"key":"key\n\t\t\t\t20180328150728_euw169C24","doi-asserted-by":"crossref","first-page":"P4067","DOI":"10.1093\/eurheartj\/eht309.P4067","article-title":"Carotid intima-media thickness, carotid distensibility, and incident atrial fibrillation: the Multi-Ethnic Study of Atherosclerosis (MESA)","volume":"34","author":"Chen","year":"2013","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180328150728_euw169C25","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.atherosclerosis.2014.12.022","article-title":"Relationship between carotid intima-media thickness and non valvular atrial fibrillation type","volume":"238","author":"Proietti","year":"2015","journal-title":"Atherosclerosis"},{"key":"key\n\t\t\t\t20180328150728_euw169C26","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1161\/CIRCULATIONAHA.114.014145","article-title":"Atrial fibrillation and risk of ST-segment elevation versus non-ST segment elevation myocardial infarction: the Atherosclerosis Risk in Communities (ARIC) Study","volume":"131","author":"Soliman","year":"2015","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180328150728_euw169C27","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1016\/j.hrthm.2014.08.003","article-title":"Acute myocardial infarction in patients with atrial fibrillation with a CHA2DS2-VASc score of 0 or 1: a nationwide cohort study","volume":"11","author":"Chao","year":"2014","journal-title":"Heart Rhythm"},{"key":"key\n\t\t\t\t20180328150728_euw169C28","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ejvs.2010.03.003","article-title":"Prognosis of atrial fibrillation in patients with symptomatic peripheral arterial disease: data from the Reduction of Atherothrombosis for Continued Health (REACH) Registry","volume":"40","author":"Winkel","year":"2010","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"key\n\t\t\t\t20180328150728_euw169C29","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1093\/eurheartj\/ehs092","article-title":"European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by re","volume":"33","author":"Perk","year":"2012","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180328150728_euw169C30","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1093\/eurheartj\/ehr211","article-title":"ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatm","volume":"32","author":"Tendera","year":"2011","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180328150728_euw169C31","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1161\/CIRCRESAHA.114.303505","article-title":"Pharmacological treatment and current management of peripheral artery disease","volume":"116","author":"Bonaca","year":"2015","journal-title":"Circ Res"},{"key":"key\n\t\t\t\t20180328150728_euw169C32","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1093\/eurheartj\/ehu080","article-title":"Statin therapy and long-term adverse limb outcomes in patients with peripheral artery disease: insights from the REACH registry","volume":"35","author":"Kumbhani","year":"2014","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180328150728_euw169C33","first-page":"CD000123","article-title":"Lipid-lowering for peripheral arterial disease of the lower limb","volume":"4","author":"Aung","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"key\n\t\t\t\t20180328150728_euw169C34","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ehj.2003.10.033","article-title":"Impact of ramipril in patients with evidence of clinical or subclinical peripheral arterial disease","volume":"25","author":"Ostergren","year":"2004","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180328150728_euw169C35","first-page":"CD003075","article-title":"Treatment of hypertension in peripheral arterial disease","volume":"12","author":"Lane","year":"2013","journal-title":"Cochrane database Syst Rev"},{"key":"key\n\t\t\t\t20180328150728_euw169C36","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1161\/CIRCULATIONAHA.112.107565","article-title":"Visit-to-visit blood pressure variability, carotid atherosclerosis, and cardiovascular events in the European Lacidipine Study on Atherosclerosis","volume":"126","author":"Mancia","year":"2012","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180328150728_euw169C37","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1177\/1074248414530508","article-title":"Calcium channel blockers in cardiovascular pharmacotherapy","volume":"19","author":"Godfraind","year":"2014","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"key\n\t\t\t\t20180328150728_euw169C38","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/0140-6736(90)91121-P","article-title":"Retardation of angiographic progression of coronary artery disease by nifedipine. Results of the International Nifedipine Trial on Antiatherosclerotic Therapy (INTACT). INTACT Group Investigators","volume":"335","author":"Lichtlen","year":"1990","journal-title":"Lancet (London, England)"},{"key":"key\n\t\t\t\t20180328150728_euw169C39","first-page":"3935","article-title":"Combined treatment with olmesartan medoxomil and amlodipine besylate attenuates atherosclerotic lesion progression in a model of advanced atherosclerosis","volume":"9","author":"Sievers","year":"2015","journal-title":"Drug Des Devel Ther"},{"key":"key\n\t\t\t\t20180328150728_euw169C40","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1161\/01.CIR.0000039288.86470.DD","article-title":"Calcium antagonist lacidipine slows down progression of asymptomatic carotid atherosclerosis: Principal results of the European Lacidipine Study on Atherosclerosis (ELSA), a randomized, double-blind, long-term trial","volume":"106","author":"Zanchetti","year":"2002","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180328150728_euw169C41","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients","volume":"324","year":"2002","journal-title":"BMJ"},{"key":"key\n\t\t\t\t20180328150728_euw169C42","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1001\/jama.2009.623","article-title":"Aspirin for the prevention of cardiovascular events in patients with peripheral artery disease: a meta-analysis of randomized trials","volume":"301","author":"Berger","year":"2009","journal-title":"J Am Med Assoc"},{"key":"key\n\t\t\t\t20180328150728_euw169C43","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1160\/TH09-09-0635","article-title":"Comparison of efficacy of antiplatelet treatments for patients with claudication. A meta-analysis","volume":"103","author":"Basili","year":"2010","journal-title":". Thromb Haemost"}],"container-title":["EP Europace"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/europace\/article-pdf\/19\/9\/1439\/19947291\/euw169.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,3,28]],"date-time":"2018-03-28T17:30:02Z","timestamp":1522258202000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/europace\/article\/19\/9\/1439\/2661547"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,9]]},"references-count":43,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2016,12,9]]},"published-print":{"date-parts":[[2017,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/europace\/euw169","relation":{},"ISSN":["1099-5129","1532-2092"],"issn-type":[{"value":"1099-5129","type":"print"},{"value":"1532-2092","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,9]]},"published":{"date-parts":[[2016,12,9]]}}}